Woodford Woes Drag On For Immunocore

Unrealistic Valuations Holding Private Firms Back

 
• By Andrew McConaghie
  
Oxford
Oxford, home to T-cell receptor immunotherapy company Immunocore
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip